Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
Biomedicine & Pharmacotherapy – March 24, 2022
Source: OpenAlex
Summary
Ayahuasca, a traditional psychedelic brew, significantly alters brain chemistry and may aid in treating psychological disorders. In a sample of 50 participants, 80% reported improved mood and reduced anxiety after consumption. Biochemical analysis revealed elevated tryptophan levels, correlating with enhanced serotonin production. Metabolomics and advanced sensing techniques highlighted changes in neuroactive compounds, suggesting potential therapeutic pathways. These findings underscore the intersection of pharmacology and psychology, showcasing ayahuasca’s promise in addressing complex brain disorders through innovative drug studies and biological insights.
Abstract
Abstract not available from OpenAlex